Corner Therapeutics, an immunotherapy companypioneering novel vaccines, announced that it has raised $54 million to create vaccines that confer lifelong protection from cancer and infectious diseases.The funding, led by Ziff Capital Partners and including Cockrell Interests, Tanis Ventures, and Sandia Holdings, will boost Corner's mission to enable the immune system to engineer long-living, disease-fighting T cells..

Corner Therapeutics是一家提供新型疫苗的免疫治疗公司，它宣布已经筹集了5400万美元用于生产能够终身预防癌症和传染病的疫苗。该资金由Ziff Capital Partners牵头，包括Cockrell Interests、Tanis Ventures和Sandia Holdings，将推动Corner的使命，使免疫系统能够设计长寿、抗病的T细胞。